{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T18:46:39Z","timestamp":1760985999809,"version":"build-2065373602"},"reference-count":23,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","meddos.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Dosimetry"],"published-print":{"date-parts":[[2021]]},"DOI":"10.1016\/j.meddos.2020.12.003","type":"journal-article","created":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T19:21:17Z","timestamp":1610565677000},"page":"229-235","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Proton beam therapy can achieve lower vertebral bone marrow dose than photon beam therapy during chemoradiation therapy of esophageal cancer"],"prefix":"10.1016","volume":"46","author":[{"given":"Yin","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salma K.","family":"Jabbour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ning J.","family":"Yue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nrusingh C.","family":"Biswal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.meddos.2020.12.003_bib0001","first-page":"7","article-title":"Cancer statistics, 2018 [published online ahead of print 2018\/01\/10]","volume":"68","author":"Siegel","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.meddos.2020.12.003_bib0002","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S0140-6736(12)60643-6","article-title":"Oesophageal carcinoma","volume":"381","author":"Pennathur","year":"2013","journal-title":"The Lancet"},{"key":"10.1016\/j.meddos.2020.12.003_bib0003","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1200\/JCO.2007.12.9593","article-title":"Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781 [published online ahead of print 2008\/03\/04]","volume":"26","author":"Tepper","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.meddos.2020.12.003_bib0004","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.adro.2017.06.002","article-title":"Clinical outcomes of intensity modulated proton therapy and concurrent chemotherapy in esophageal carcinoma: A single institutional experience","volume":"2","author":"Prayongrat","year":"2017","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.meddos.2020.12.003_bib0005","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20160350","article-title":"Dosimetric predictors of acute haematological toxicity in oesophageal cancer patients treated with neoadjuvant chemoradiotherapy","volume":"89","author":"Lee","year":"2016","journal-title":"Br J Radiol"},{"key":"10.1016\/j.meddos.2020.12.003_bib0006","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ijrobp.2015.09.022","article-title":"Thoracic vertebral body irradiation contributes to acute hematologic toxicity during chemoradiation therapy for non-small cell lung cancer","volume":"94","author":"Deek","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.meddos.2020.12.003_bib0007","doi-asserted-by":"crossref","first-page":"513","DOI":"10.21037\/jgo.2019.01.20","article-title":"Vertebral body irradiation during chemoradiation therapy for esophageal cancer contributes to acute bone marrow toxicity","volume":"10","author":"Zhang","year":"2019","journal-title":"J Gastrointest Oncol"},{"key":"10.1016\/j.meddos.2020.12.003_bib0008","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.ijrobp.2017.07.025","article-title":"Potential of proton therapy to reduce acute hematologic toxicity in concurrent chemoradiation therapy for esophageal cancer","volume":"99","author":"Warren","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.meddos.2020.12.003_bib0009","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ijrobp.2016.01.044","article-title":"An analysis of plan robustness for esophageal tumors: Comparing volumetric modulated arc therapy plans and spot scanning proton planning [published online ahead of print 2016\/04\/17]","volume":"95","author":"Warren","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.meddos.2020.12.003_bib0010","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.ijrobp.2015.03.030","article-title":"Expert consensus contouring guidelines for intensity modulated radiation therapy in esophageal and gastroesophageal junction cancer","volume":"92","author":"Wu","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.meddos.2020.12.003_bib0011","unstructured":"Raben D, Ridge JA, Wong S, et. al. A randomized phase II trial of chemiradiotherapy versus chemoradiotherapy and vandetanib for high-risk postoperative advanced squamous cell carcinoma of the had and neck. RTOG-0619:1\u201371; 2008."},{"key":"10.1016\/j.meddos.2020.12.003_bib0012","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1759-7714.2010.00017.x","article-title":"Intensity modulated radiation therapy in the treatment of esophageal cancer [published online ahead of print 2010\/07\/01]","volume":"1","author":"Yap","year":"2010","journal-title":"Thorac Cancer"},{"key":"10.1016\/j.meddos.2020.12.003_bib0013","doi-asserted-by":"crossref","first-page":"66","DOI":"10.4103\/0971-6203.51932","article-title":"Static versus dynamic intensity-modulated radiotherapy: Profile of integral dose in carcinoma of the nasopharynx","volume":"34","author":"Jothybasu","year":"2009","journal-title":"J Med Phys"},{"key":"10.1016\/j.meddos.2020.12.003_bib0014","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.adro.2017.03.006","article-title":"Dosimetric and clinical outcomes after volumetric modulated arc therapy for carcinoma of the thoracic esophagus","volume":"2","author":"Xu","year":"2017","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.meddos.2020.12.003_bib0015","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.jcma.2016.01.013","article-title":"Feasibility of intensity-modulated radiotherapy for esophageal cancer in definite chemoradiotherapy","volume":"79","author":"Hsieh","year":"2016","journal-title":"J Chin Med Assoc"},{"key":"10.1016\/j.meddos.2020.12.003_bib0016","doi-asserted-by":"crossref","first-page":"133","DOI":"10.4236\/ijmpcero.2013.24018","article-title":"Dosimetric study of coplanar and non-coplanar intensity-modulated radiation therapy planning for esophageal carcinoma","volume":"02","author":"Li","year":"2013","journal-title":"Int J Med Phys, Clin Eng Radiat Oncol"},{"key":"10.1016\/j.meddos.2020.12.003_bib0017","doi-asserted-by":"crossref","first-page":"e750","DOI":"10.1097\/MD.0000000000000750","article-title":"Comparing treatment plan in all locations of esophageal cancer: volumetric modulated arc therapy versus intensity-modulated radiotherapy","volume":"94","author":"Lin","year":"2015","journal-title":"Med (Baltimore)"},{"key":"10.1016\/j.meddos.2020.12.003_bib0018","doi-asserted-by":"crossref","first-page":"E635","DOI":"10.1016\/j.ijrobp.2017.06.2136","article-title":"Dosimetric Comparison of Coplanar Volumetric Modulated Arc Therapy and Non-coplanar Intensity Modulated Radiation Therapy for Pancreatic Cancer","volume":"99","author":"Badkul","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.meddos.2020.12.003_bib0019","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/S0360-3016(00)01555-8","article-title":"Methodologies and Tools for Proton Beam Design for Lung Tumors","volume":"49","author":"Moyers M","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.meddos.2020.12.003_bib0020","unstructured":"Liao, Z; Bradley, J; Choi, N; et. al. Phase III Randomized trial comparing overall survival after photon versus proton chemoradiotherapy for inoperable stage II-IIIB NSCLC. RTOG-1308, 2014."},{"key":"10.1016\/j.meddos.2020.12.003_bib0021","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1016\/j.jtho.2018.05.028","article-title":"Dosimetric predictors of symptomatic cardiac events after conventional-dose chemoradiation therapy for inoperable NSCLC","volume":"13","author":"Yegya-Raman","year":"2018","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.meddos.2020.12.003_bib0022","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s13045-018-0683-4","article-title":"Proton beam therapy for cancer in the era of precision medicine","volume":"11","author":"Hu","year":"2018","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.meddos.2020.12.003_bib0023","doi-asserted-by":"crossref","first-page":"155","DOI":"10.21037\/jgo.2018.09.06","article-title":"Novel use of proton beam therapy for neoadjuvant treatment of radiation-associated squamous cell carcinoma of the esophagus","volume":"10","author":"Patel","year":"2019","journal-title":"J Gastrointest Oncol"}],"container-title":["Medical Dosimetry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0958394720301667?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0958394720301667?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T09:31:48Z","timestamp":1760693508000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0958394720301667"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021]]}},"alternative-id":["S0958394720301667"],"URL":"https:\/\/doi.org\/10.1016\/j.meddos.2020.12.003","relation":{},"ISSN":["0958-3947"],"issn-type":[{"type":"print","value":"0958-3947"}],"subject":[],"published":{"date-parts":[[2021]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Proton beam therapy can achieve lower vertebral bone marrow dose than photon beam therapy during chemoradiation therapy of esophageal cancer","name":"articletitle","label":"Article Title"},{"value":"Medical Dosimetry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.meddos.2020.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 American Association of Medical Dosimetrists. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}